C.diff | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

86 results for “C.diff”

Trials

View all 39 →

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

10 participants · First posted Mar 17, 2006

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

413 participants · First posted Sep 29, 2015

C.Difficile Observational Study

7 participants · First posted Feb 26, 2024

Drugs

ACAM-CDIFF

Anti-LAG-3(Cardiff University)

dUTPase inhibitors(University of Cardiff)

Organizations

CARDIFF UNIVERSITY

United Kingdom

Cardiff Oncology

United States

CARDIFF METROPOLITAN UNIVERSITY

United Kingdom

News

View all 36 →

New Study Raises Safety Concerns About Fecal Microbiota Transplants

Cardiff Oncology's Onvansertib Shows Promise in Metastatic Castration-Resistant Prostate Cancer

Cardiff Oncology's Onvansertib Shows Promising Results in RAS-Mutated Metastatic Colorectal Cancer Trial

Page 1 of 9